Marco Bozzali
Overview
Explore the profile of Marco Bozzali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
197
Citations
3589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Kasper S, Antonelli Incalzi R, Bozzali M, Morgado P, Siwek M
Int Clin Psychopharmacol
. 2025 Jan;
PMID: 39803748
This study aims to elucidate current trends in clinical practice for managing depression in elderly patients, focusing on the utilization of pharmacotherapeutics and integrated care models to improve patient outcomes....
3.
Imperiale D, Atzori C, Angeloro D, Murgioni A, Bagatin A, Secci V, et al.
J Alzheimers Dis
. 2024 Dec;
103(1):305-315.
PMID: 39623969
Background: Alzheimer's disease (AD) is the most common neurodegenerative dementia, with diagnosis traditionally reliant on clinical criteria. Cerebrospinal fluid (CSF) biomarkers like pTau181 and Aβ/Aβ ratio significantly improve diagnostic accuracy...
4.
Serra L, Bonarota S, Di Domenico C, Caruso G, Giulietti G, Rizzuti M, et al.
J Alzheimers Dis
. 2024 Nov;
102(1):181-194.
PMID: 39497309
Background: Reserves' mechanisms explain inconsistencies between accumulation of neuropathological damage and clinical manifestations. Leisure activities are believed to promote reserves. Objective: This study evaluates whether cognitive, social, and physical leisure...
5.
Danciut I, Rae C, Rashid W, Scott J, Bozzali M, Iancu M, et al.
Brain Commun
. 2024 Sep;
6(5):fcae292.
PMID: 39291169
One of the most prominent symptoms in multiple sclerosis is pathological fatigue, often described by sufferers as one of the most debilitating symptoms, affecting quality of life and employment. However,...
6.
Sacchi L, DAgata F, Campisi C, Arcaro M, Carandini T, Orzsik B, et al.
Hum Brain Mapp
. 2024 Aug;
45(12):e26805.
PMID: 39185685
The glymphatic system (GS) is a whole-brain perivascular network, consisting of three compartments: the periarterial and perivenous spaces and the interposed brain parenchyma. GS dysfunction has been implicated in neurodegenerative...
7.
Ledda C, Imbalzano G, Tangari M, Covolo A, Donetto F, Montanaro E, et al.
Parkinsonism Relat Disord
. 2024 Jul;
126:107073.
PMID: 39067322
Background: Non-motor symptoms and non-motor fluctuations (NMF) in Parkinson's disease (PD) strongly affect health-related quality of life (HRQoL) and disability. The impact of deep brain stimulation (DBS) on NMF remains...
8.
Mencarelli L, Torso M, Borghi I, Assogna M, Pezzopane V, Bonni S, et al.
Alzheimers Res Ther
. 2024 Jul;
16(1):152.
PMID: 38970141
Alzheimer's Disease (AD) is characterized by structural and functional dysfunction involving the Default Mode Network (DMN), for which the Precuneus (PC) is a key node. We proposed a randomized double-blind...
9.
Serra L, Petrucci A, Bruschini M, Botta A, Campisi C, Caltagirone C, et al.
Neuromuscul Disord
. 2024 May;
40:24-30.
PMID: 38810327
We report on genetic and environmental modulation of social cognition abilities and brain volume correlates in two monozygotic twins (Twin1 and Twin2) with genetically confirmed myotonic dystrophy-type1 who grew up...
10.
Imbalzano G, Artusi C, Ledda C, Montanaro E, Romagnolo A, Rizzone M, et al.
J Parkinsons Dis
. 2024 May;
14(4):843-853.
PMID: 38728203
Background: Gait issues, including reduced speed, stride length and freezing of gait (FoG), are disabling in advanced phases of Parkinson's disease (PD), and their treatment is challenging. Levodopa/carbidopa intestinal gel...